Disal
Disal® (furosemide injection) 50 mg/mL
Approved
Approval ID
88f58baf-4ec5-4d6f-a447-68af4b239318
Product Type
PRESCRIPTION ANIMAL DRUG LABEL
Effective Date
Apr 28, 2025
Manufacturers
FDA
Boehringer Ingelheim Animal Health USA Inc.
DUNS: 007134091
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Furosemide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0010-6737
Application NumberNADA131538
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 28, 2025
FDA Product Classification
INGREDIENTS (7)
FUROSEMIDEActive
Quantity: 50 mg in 1 mL
Code: 7LXU5N7ZO5
Classification: ACTIB
MIRIPIRIUM CHLORIDEInactive
Quantity: 0.2 mg in 1 mL
Code: 3D6CWI0P23
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 1 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM SULFITEInactive
Quantity: 1 mg in 1 mL
Code: VTK01UQK3G
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 2 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
2-AMINOETHANOLInactive
Quantity: 10 mg in 1 mL
Code: 5KV86114PT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT